Table 2.
Concentrations of Endocrine disruptor chemicals (EDCs) in the mothers of all adolescents.
| EDCs/hormones |
All participants |
With male adolescents |
With female adolescents |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | Mean ± std | Median | IQR | n | Mean ± std | Median | IQR | n | Mean ± std | Median | IQR | |
| Cord Blood | ||||||||||||
| PFHxS (ng/mL) | 46 | 26.05 ± 14.85 | 25.65 | 16.2–31.35 | 24 | 26.01 ± 17.19 | 23.95 | 13.38–29.48 | 22 | 26.09 ± 12.2 | 26.35 | 17.65–33.55 |
| PFOA (ng/mL) | 46 | 1.36 ± 1.4 | 0.81 | 0.23–2.36 | 24 | 1.28 ± 1.38 | 0.77 | 0.23–2.41 | 22 | 1.45 ± 1.44 | 0.84 | 0.23–2.21 |
| PFNA (ng/mL) | 46 | 1.4 ± 1.69 | 0.8 | 0.25–1.77 | 24 | 1.36 ± 1.89 | 0.73 | 0.08–1.4 | 22 | 1.45 ± 1.5 | 0.94 | 0.39–1.96 |
| PFOS (ng/mL) | 46 | 5.46 ± 4.74 | 4.22 | 2.55–6.45 | 24 | 5.04 ± 4.44 | 3.52 | 2.13–6.85 | 22 | 5.93 ± 5.12 | 4.5 | 3.3–6.2 |
| PFDeA (ng/mL) | 46 | 0.28 ± 0.32 | 0.1 | 0.1–0.42 | 24 | 0.26 ± 0.31 | 0.1 | 0.1–0.32 | 22 | 0.3 ± 0.34 | 0.1 | 0.1–0.51 |
| PFUA (ng/mL) | 46 | 4.01 ± 6.84 | 1.36 | 0.07–3.01 | 24 | 4.12 ± 7.92 | 1.45 | 0.07–2.72 | 22 | 3.89 ± 5.6 | 1.07 | 0.07–4.75 |
| PFDoA (ng/mL) | 46 | 0.29 ± 0.28 | 0.21 | 0.04–0.39 | 24 | 0.25 ± 0.31 | 0.16 | 0.04–0.34 | 22 | 0.34 ± 0.25 | 0.28 | 0.18–0.5 |
| Mother Urine | ||||||||||||
| Urinary creatinine (mg/dL) | 45 | 82.57 ± 56.23 | 61.69 | 38.52–121.48 | 24 | 94.02 ± 66.04 | 80.03 | 42.54–128.91 | 21 | 69.48 ± 40.05 | 58.66 | 36.33–95.26 |
| MMP (µg/L) | 45 | 52.89 ± 35.89 | 47.57 | 22.21–75.3 | 24 | 53.87 ± 36.68 | 45.58 | 29.76–77.37 | 21 | 51.76 ± 35.83 | 49.34 | 19.75–73.61 |
| MEP (µg/L) | 45 | 53.16 ± 57.01 | 36.96 | 24.46–53.73 | 24 | 62.62 ± 69.51 | 41.4 | 27.32–55.56 | 21 | 42.34 ± 36.93 | 32.35 | 20.52–50.27 |
| MBP (µg/L) | 45 | 58.43 ± 45.94 | 45.02 | 21.26–78.41 | 24 | 65.77 ± 47.22 | 52.56 | 30.72–105.97 | 21 | 50.04 ± 44.05 | 39.44 | 20.84–58.78 |
| MBzP (µg/L) | 45 | 12.5 ± 10.26 | 8.87 | 5.8–15.43 | 24 | 11.3 ± 7.71 | 9.2 | 5.46–14.42 | 21 | 13.87 ± 12.63 | 8.86 | 6.32–15.74 |
| MEOHP (µg/L) | 45 | 33.94 ± 64.36 | 8.64 | 5.69–25.58 | 24 | 48.56 ± 83.76 | 9.29 | 5.36–36.5 | 21 | 17.23 ± 22.21 | 8.64 | 5.82–17.09 |
| MEHHP (µg/L) | 45 | 19.07 ± 39.12 | 7.07 | 4.02–14.76 | 24 | 28.46 ± 51.77 | 6.92 | 4.47–20.31 | 21 | 8.33 ± 7.57 | 7.69 | 2.43–9.67 |
| MEHP (µg/L) | 45 | 15.86 ± 24.79 | 9.81 | 7.49–14.53 | 24 | 20.19 ± 33.11 | 10.89 | 8.49–18.62 | 21 | 10.9 ± 6.55 | 8.78 | 7.08–11.93 |
| DEHP (µg/L) | 45 | 68.87 ± 119.49 | 27.12 | 17.53–55.14 | 24 | 97.22 ± 157.39 | 32.96 | 18.19–57.4 | 21 | 36.46 ± 29.31 | 22.28 | 15.93–51.26 |
| Mother Serum | ||||||||||||
| PFHxS (ng/mL) | 45 | 1.03 ± 2.37 | 0.79 | 0.04–1.08 | 23 | 1.39 ± 3.24 | 0.82 | 0.16–1.12 | 22 | 0.64 ± 0.69 | 0.64 | 0.04–1 |
| PFOA (ng/mL) | 45 | 2.85 ± 4.39 | 2.5 | 1.06–2.97 | 23 | 3.61 ± 5.85 | 2.64 | 1.96–3.1 | 22 | 2.06 ± 1.81 | 1.92 | 0.23–2.68 |
| PFNA (ng/mL) | 45 | 1.55 ± 1.58 | 1.18 | 0.59–1.8 | 23 | 2.03 ± 2.03 | 1.41 | 0.8–2.47 | 22 | 1.04 ± 0.61 | 0.88 | 0.59–1.63 |
| PFOS (ng/mL) | 45 | 14.1 ± 9.95 | 11.3 | 9.79–17.42 | 23 | 15.55 ± 12.78 | 10.95 | 9.89–17.84 | 22 | 12.58 ± 5.63 | 12.13 | 8.8–17.15 |
| PFDeA (ng/mL) | 45 | 0.45 ± 0.29 | 0.43 | 0.27–0.6 | 23 | 0.5 ± 0.34 | 0.38 | 0.26–0.75 | 22 | 0.4 ± 0.21 | 0.43 | 0.28–0.48 |
| PFUA (ng/mL) | 45 | 4.25 ± 5.41 | 2.45 | 1.27–4.34 | 23 | 5.39 ± 7.01 | 2.72 | 1.22–8.03 | 22 | 3.05 ± 2.65 | 2.43 | 1.32–3.32 |
| PFDoA (ng/mL) | 45 | 0.31 ± 0.23 | 0.3 | 0.12–0.39 | 23 | 0.35 ± 0.3 | 0.31 | 0.04–0.58 | 22 | 0.26 ± 0.13 | 0.29 | 0.23–0.34 |
PFHxS: perfluorohexanesulfonic acid. PFOA: perfluorooctanoic acid. PFNA: perfluorononanoic acid. PFOS: perfluorooctane sulfonate. PFDeA perfluorodecanoic acid. PFUA: perfluoroundecanoic acid. PFDoA: perfluorododecanoic acid. MEP: mono-ethyl phthalate. MMP: mono-methyl phthalate. MBP: mono-butyl phthalate. MBzP: mono-benzyl phthalate. MEHP: mono-2-ethylhexyl phthalate. MEHHP: mono-2-ethyl-5-hydroxyhexyl phthalate. MEOHP: mono- 2-ethyl-5-oxohexyl phthalate. DEHP: di-2-ethyl-hexyl phthalate.